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Abstract
Background: Formin proteins utilize a conserved formin homology 2 (FH2) domain to nucleate new actin filaments. In
mammalian diaphanous-related formins (DRFs) the FH2 domain is inhibited through an unknown mechanism by
intramolecular binding of the diaphanous autoinhibitory domain (DAD) and the diaphanous inhibitory domain (DID).
Methodology/Principal Findings: Here we report the crystal structure of a complex between DID and FH2-DAD fragments
of the mammalian DRF, mDia1 (mammalian diaphanous 1 also called Drf1 or p140mDia). The structure shows a tetrameric
configuration (4 FH2 + 4 DID) in which the actin-binding sites on the FH2 domain are sterically occluded. However
biochemical data suggest the full-length mDia1 is a dimer in solution (2 FH2 + 2 DID). Based on the crystal structure, we
have generated possible dimer models and found that architectures of all of these models are incompatible with binding to
actin filament but not to actin monomer. Furthermore, we show that the minimal functional monomeric unit in the FH2
domain, termed the bridge element, can be inhibited by isolated monomeric DID. NMR data on the bridge-DID system
revealed that at least one of the two actin-binding sites on the bridge element is accessible to actin monomer in the
inhibited state.
Conclusions/Significance: Our findings suggest that autoinhibition in the native DRF dimer involves steric hindrance with
the actin filament. Although the structure of a full-length DRF would be required for clarification of the presented models,
our work here provides the first structural insights into the mechanism of the DRF autoinhibition.
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Introduction
Formins are conserved actin regulators, which function in
formation of stress fibers, actin cables, the cytokinetic ring and
filopodia [1–4]. Unlike the branched network of short actin
filaments generated by the Arp2/3 complex [5–8], formin activity
results in unbranched, long filaments in cells [9,10]. Formins
modulate actin dynamics through two biochemical activities. They
accelerate nucleation of new filaments de novo from actin
monomers. Following nucleation they also remain stably associ-
ated at the barbed-ends of growing filaments as actin monomers
are added, in a process termed ‘‘processive capping’’ [10–15].
Both in cells and in vitro, processive capping allows formins to
protect the filament barbed ends from capping proteins and to
modulate rates of filament elongation [11,12,16,17].
These actin regulatory activities are carried out by the
conserved formin homology 2 (FH2) domain [18,19]. Crystal
structures of the FH2 domain of the yeast formin Bni1p in
isolation and in complex with actin have shed light on structural
mechanisms of FH2 function [20,21]. The FH2 domain forms a
ring-like dimer in which two structural units, referred to as actin
bridge elements (BEs) or hemi-dimers, are connected through two
flexible linkers (Fig. 1A). In the actin complex structure, each
bridge element holds two actin monomers whose relative
orientation is similar to the short-pitch dimer of an actin filament,
suggesting nucleation through a templating mechanism [21].
Several different models for processive capping have been
proposed, involving various modes of formin and actin fluctuations
at the filament barbed end, which would allow the formin to
remain persistently bound, while new monomers are added
[11,13,21–25].
Diaphanous-related formins (DRFs) including mDia, Daam and
FRL are effectors of Rho family GTPases, which function in
processes such as cell migration, cytokinesis, cell polarity signaling,
phagocytosis, and cancer metastasis [19,26–30]. In isolation,
DRFs are autoinhibited through binding of a C-terminal
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follows the FH2 domain in sequence, and an N-terminal
diaphanous inhibitory domain (DID) [31–33] (Fig. 1A). Auto-
inhibition is relieved by GTP-bound Rho proteins, which bind to
the DID and an adjacent GTPase binding (G) element, and
consequently displace the DAD. Structural studies have shown
that the Rho and DAD binding sites on the DID are partially
overlapped, explaining incompatibility of the two interactions [34–
36]. The G-DID element of mDia1 is rendered dimeric through
an adjacent dimerization domain (DD) and coiled coil region (CC)
(Fig. 1A) [32,34,35]. Although the mechanisms of Rho-mediated
activation of DRFs are reasonably clear, the mechanism of
autoinhibition is not, in part because the FH2 domain shows no
detectable binding to any other domains in DRF in isolation
[32,36]. This contrasts to other autoinhibited systems (e.g. WASP
or Pak), in which activity bearing domains often bind to inhibitory
domains directly with functionally critical residues being masked
by the interaction [37–39].
Here we report the crystal structure of an autoinhibitory
complex of mDia1 formed in trans between the DID-DD and FH2-
DAD fragments of the protein. The structure exhibits a tetrameric
configuration that contains four chains each of the DID-DD and
FH2-DAD. Sedimentation equilibrium ultracentrifugation and
multi-angle static light scattering (MALS) data indicate that the
complex used for crystallization equilibrates between a dimer and
a tetramer in solution. In contrast, full-length mDia1 and another
complex formed in trans between FH2-DAD and a longer N-
terminal fragment containing the DID-DD and an adjacent
coiled-coil region are both dimers. The dimeric configurations that
can be extracted from our crystal structure appear to be
incompatible with filament binding, suggesting a likely mechanism
of autoinhibition. However, additional NMR and biochemical
analyses of a minimal element of this system (a monomeric bridge-
DAD construct bound to DID) suggest that the autoinhibited
structure may allow actin monomers to bind at least one of the two
actin-binding sites on the FH2 domain.
Results and Discussion
Full-length mDia1 Forms a Dimer in Solution
Structural and biochemical studies have revealed that FH2
domains and the N-terminal regulatory fragment of mDia1 (G-
DID-DD-CC, Fig. 1A) form dimers in isolation [32,34,35]. To
determine if full-length mDia1 is also a dimer, we analyzed the
intact protein as well as two intermolecular complexes of N- and
C-terminal fragments (Fig. 1A) using sedimentation equilibrium
ultracentrifugation and MALS. For full-length mDia1, the
sedimentation equilibrium data can be described well by a single
ideal species model, yielding a molecular mass of 232 kDa, which
is reasonably close to the dimer mass (255 kDa) (Fig. 1B). The
MALS-derived mass, 274 kDa, is also consistent with a
predominantly dimeric species (Fig. 1F). For the intermolecular
N+C complex of G-DID-DD-CC and FH2-DAD, both ultra-
centrifugation and MALS data give a mass consistent with two
chains each of G-DID-DD-CC and FH2-DAD (190 kDa and
221 kDa, respectively, versus 221 kDa calculated mass) (Fig. 1C
and G). Thus, full-length mDia1 and the complex of G-DID-DD-
CC plus FH2-DAD produce analogous stoichiometries. In
contrast, when the ultracentrifugation data on the complex of
FH2-DAD plus DID-DD,a minimal dimeric inhibitoryfragment,
are fit to a single species model, the resulting mass (251 kDa) does
not agree well with the calculated mass of the dimer (181 kDa)
(Fig. 1D). However, the data fit well to a two species model ((DID-
DDNFH2-DAD)2 + (DID-DDNFH2-DAD)4) with a dissociation
constant of 14.6 mM (Fig. 1E). MALS data are also consistent
with multiple species as indicated by a broad peak eluting from
the prior gel filtration chromatography column, with masses
ranging from 267 kDa (peak2) to 332 kDa (peak1) (Fig. 1H). The
mass of 332 kDa is close to that of the (DID-DD/FH2-DAD)4
tetramer, 362 kDa. On this basis we conclude that the DID-
DDNFH2-DAD complexlikelyequilibratesbetweena dimerand a
tetramer in solution. Thus, the CC region appears to stabilize the
dimer relative to the tetramer. Notably, the absence of the CC
region does not affect the oligomerization state of the DID-DD
fragment (Fig. S1) and G-DID-DD-CC and DID-DD inhibit
FH2-DAD with equal potency in in vitro actin assembly assays
(Fig. S2).
Crystallization of an Autoinhibited Complex of mDia1
We attempted crystallization of mDia1 in the autoinhibited
conformation using two separate chains of the N- and C-terminal
domains, since the FH1 poly-proline region (,200 residues) in the
central segment of full-length mDia1 would likely interfere with
crystallization. The FH2-DAD construct spanning residues 753–
1209 was chosen based on previous structures of the FH2 and
DAD region of various formins [36,40,41]. This was paired with a
number of N-terminal constructs containing different lengths of
the CC region. Only the construct completely lacking the CC
region (residues 131–457, DID-DD) yielded crystals in complex
with FH2-DAD. These diffracted to 2.75 A ˚ under synchrotron
illumination (Table 1). Phase information was obtained from a
combination of a molecular replacement experiment and a multi-
wavelength anomalous dispersion experiment collected on a
selenomethionine-labeled sample.
Structure of an Autoinhibitory Complex of mDia1
In the crystal (Fig. 2A), an asymmetric unit contains four chains
each of DID-DD and FH2-DAD, consistent with the heavier mass
observed in our ultracentrifugation and MALS data above. These
are organized into two dimers of DID-DD (blue and grey in
Fig. 2A), each of which is bound to a DAD element (red), and four
bridge elements (dark/light green and dark/light tan). The linkers
Figure 1. Domain organization and oligomerization of mDia1. (A) Domain organization of mDia1. Abbreviations: G, GTPase binding region
necessary for RhoA binding; DID, Diaphanous inhibitory domain; DD, dimerization domain; CC, coiled coil; FH1, formin homology 1 domain; FH2,
formin homology 2 domain; DAD, Diaphanous autoinhibitory domain. (B-E) Sedimentation equilibrium analyses of (B) full-length protein, (C) the G-
DID-DD-CCNFH2-DAD and (D, E) the DID-DDNFH2-DAD complex. Representative data recorded for each protein/complex with a sample concentration
of 14 mM at 6500 (blue diamonds), 9500 (red triangles), and 12000 rpm (green circles) are shown. The curves were fitted with single ideal species or
monomer model in (B-D) and monomer-dimer equilibrium model in (E), respectively. In (E), the molecular weight of the monomer was fixed to
181kDa, which corresponds to the sum of two chains of each of DID-DD and FH2-DAD. The dissociation constant obtained from the fitting is 14.6 mM.
Above these data are the residuals between the data and the fitted lines. (F-H) Size exclusion chromatography (Superdex 200) coupled multi-angle
static light scattering experiments for (F) full-length protein, (G) the G-DID-DD-CCNFH2-DAD and (H) the DID-DDNFH2-DAD complex. Representative
signals from the 90u detector (red) and refractive index differences (blue) are shown (upper panels). The two vertical solid lines indicate the regions
used for calculating average molar mass (upper panels). The calculated molecular weights for each data point are shown as black diamonds in the
expanded pictures of the selected regions (lower panels). 500 ml of total 25 mM protein were injected.
doi:10.1371/journal.pone.0012896.g001
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nor are the connections from bridge to DAD.
Within each (DID-DD)2 dimer, the structures of the individual
sub-domains, and the contacts between the DDs are essentially the
same as observed in previous structures of mDia1 N-terminal
fragments (Fig. 2A and 2B) [34,35,40]. The DID is folded into a
superhelical architecture with five repeats of a three helix element.
The DD consists of three helices from each chain, which
interdigitate with one another to create a dimer of six helices.
The DID is bent slightly along its long axis. The pair-wise root
mean square distances (r.m.s.d.s) of backbone heavy atoms
between our structure and known mDia1 crystal structures are
less than 1.5 A ˚ for the DID and 2.2 A ˚ for the DD in isolation
(Table 2). However, the relative orientation between DID and DD
is quite different among the available structures, resulting in
differences in the relative positions of two DIDs of each (DID-
DD)2 dimer (Fig. 2B). In the autoinhibited structure presented
here, the long axes of the DID elements are roughly collinear, with
a relative angle of 167u, and the DD dimer is slightly displaced
perpendicularly to this axis. The two DID axes are related by 154u
in the RhoC complex (PDB code:1Z2C), by 126u in the DAD
complex (2BAP), and by 64u in the free structure (2BNX). The
different orientations between DID and DD among the various
crystal structures suggest that these elements likely sample a wide
range of conformations in solution. Interestingly, of all the mDia1
N-terminal fragments crystallized to date, only the free DID-DD-
CC exhibits an asymmetric conformation in the crystal [34]. This
lack of symmetry may be important in producing dimers rather
than tetramers in full-length mDia1 (Fig. 1).
In the previously reported structures of the FH2 domains of
yeast Bni1p and human Daam1 each bridge element consists of an
elongated helical bundle with two helical domains at either end,
termed the knob and post respectively. The bridges are connected
at both ends by a so-called lasso element that extends from the
knob of one bridge to wrap around the post of its partner, creating
a closed ring. Binding of actin to both the knob and post sites of
each bridge element is necessary for processive capping by Bni1p,
and likely formins in general. A previous report described the
structure of an mDia1 FH2 fragment lacking the lasso region
(836–1169) [41]; the complete FH2 structure here is very similar,
with backbone r.m.s.d. of 1.9 A ˚. The mDia1 lasso wraps around
the post region as seen in Bni1p and Daam1, confirming a
Table 1. Data collection, phasing and refinement statistics for mDia1 DID-DDNFH2-DAD complex.
Data collection
Crystal SeMet #1 (Se
a peak) SeMet #1 (Se
a inflection point) SeMet #2 (Se
a peak) Native
Wavelength (A ˚) 0.97937 0.97954 0.97946 0.97937
Resolution range (A ˚) 48.4–2.95 (3.00–2.95) 48.7–3.20 (3.27–3.20) 48.6 – 3.45 (3.5–3.45) 48.5–2.75 (2.81–2.75)
Unique reflections 102,553 (4,576) 81,256 (4,919) 65,944 (3,297) 123,292 (5,203)
Multiplicity 3.4 (2.3) 4.0 (2.6) 4.2 (4.2) 3.7 (2.3)
Data completeness (%) 97.1 (83.7) 99.2 (90.1) 100.0 (100.0) 95.4 (60.5)
Rmerge (%)
b 8.2 (39.3) 7.3 (62.9) 12.7 (56.1) 5.4 (50.1)
I/s(I) 16.6 (1.6) 20.7 (1.5) 14.3 (2.7) 21.3 (1.4)
Wilson B-value (A ˚2) 89.5 103.2 89.7 84.0
Phase determination
Anomalous scatterers selenium, 15 out of 15 possible sites
Figure of merit (35.0–2.95 A ˚) 0.20
Refinement statistics
Resolution range (A ˚) 29.9–2.75 (2.85–2.75)
No. of reflections Rwork/Rfree 122,258/1,799 (8,435/124)
Data completeness (%) 95.8 (67.0)
Atoms (non-H protein) 24,224
Rwork (%) 19.9 (35.2)
Rfree (%) 26.1 (42.6)
R.m.s.d. bond length (A ˚) 0.009
R.m.s.d. bond angle (u) 1.35
Mean B-value (A ˚2) 101.2
Ramachandran plot (%) (favored/additional/disallowed)
c 94.1/5.5/0.4
Maximum likelihood coordinate error 0.45
Missing residues, by chain A: 453–457, 753, 806–828, 1196–1209.
B: 131, 193–199, 753, 806–829, 1197–1209.
C: 453–457, 753, 806–829, 1197–1209.
D: 753, 806–829, 1197-1209.
Data for the outermost shell are given in parentheses.
aBijvoet-pairs were kept separate for data processing.
bRmerge=100 ShSi|Ih, i— ÆIhæ|/ShSiIh, i, where the outer sum (h) is over the unique reflections and the inner sum (i) is over the set of independent observations of each
unique reflection.
cAs defined by the validation suite MolProbity [55].
doi:10.1371/journal.pone.0012896.t001
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PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e12896Figure 2. Crystal structure of autoinhibited tetrameric mDia1. (A) Structure of tetrameric mDia1 in three orientations. Abbreviation: BE,
bridge element. (B) Overlay of the N-terminal inhibitory domain (DID-DD) of mDia1 from various crystal structures: the DID-DDNFH2-DAD complex
(blue, this work), the free DID-DD-CC (pink, PDB code:2BNX), the DID-DDNDAD complex (yellow, 2BAP), and the RhoC-G-DID-DD complex (orange,
1Z2C). One of the two DIDs in each dimeric DID-DD structure is superimposed (left, sky blue DID) to illustrate the differences in position of the other
DIDs. For clarity, the structures solved as complexes with RhoC and DAD, are shown without these binding proteins. The long axis of each DID
molecule is indicated as a green bar. (C) An overlay of the Ca models of the bridge elements of mDia1 (green for the core and red for the lasso
regions, this work), Daam1 (yellow, PDB code: 2J1D) and Bni1p (gray, 1Y64) is shown. The key residues that are critical for the activities and are
identified by earlier works on Bni1p yeast formin (Ile 1431 in the Knob site and Lys 1601 in the Post site) [20,21,41] are shown in sphere model with
their side-chains. The lysines in the Post site are well superposed but isoleucines in the Knob site are not. (D) An expanded view of the aT-DAD
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backbone r.m.s.d.s between the bridge element of mDia1 and
those of Bni1p and Daam1 are 3.1 A ˚ and 4.5 A ˚, respectively. The
most significant difference is in the knob domain, whose change
alters the structural relationship between the knob and the post
actin-binding sites. In the crystal structure of the Bni1p FH2-actin
complex, the two actin monomers bound to each bridge element
are related by a 180u rotation [21] (Fig. 3A). Although the exact
180u relationship in that system was likely enforced by crystallo-
graphic symmetry, the deviation from the ideal 166u angle in actin
filaments suggested that the FH2 domain might exert strain on the
filament. This, in turn, was postulated to drive fluctuations of the
bridge elements necessary for processive capping [21]. The
differences in the knob-post relationships in the mDia1, Bni1p
and Daam1 bridge elements suggest that actin would be bound to
these proteins at different angles, thus inducing different degrees of
strain on filaments. This difference could play a role in governing
the different rates of processive capping by various formin
proteins.
The absence of electron density for the linker region (806–835)
between bridge elements impairs determination of dimeric pairs of
the FH2 domain in the crystal. However, the bridge elements can
be connected to the DIDs with some confidence. The C-terminal
a-helix of the bridge element, termed aT, extends away from the
post domain for ,10 turns (Fig. 2C). At Leu1169 it connects to a
loop that joins to the a-helical region of the DAD (Val1181-
Gly1192), which is bound to the concave surface of the DID
(Fig. 2D) and ends at Phe1195. The cluster of basic residues after
Phe1195, which contributes to high affinity between the N- and C-
termini [43], is not clearly observed in our electron density map.
The weak electron density for the aT-DAD loop suggests that this
element is flexible. The interaction between the DID and DAD is
essentially the same as observed in the previously described
DIDNDAD and DID-DDNDAD complexes with backbone r.m.s.d.
of 0.6 A ˚ and 1.5 A ˚, respectively, between DAD on superimposed
DIDs [36,40].
The asymmetric unit contains four chains of the DID-DD and
bridge-DAD proteins, which form a tetrameric configuration
(Fig. 2A). In this arrangement, the two actin-binding sites on each
bridge element face toward the center of the structure, where there
is no space for actin monomers (compare Figs. 2A and 3A). The
residues important for actin-binding make contacts with other
parts of the molecules (Fig. S3). Ile845, a critical residue in the
knob site [20,21,41], makes contacts with aliphatic chains of
Gln1161, Gln1164, Lys1165 and Gln1168 from aT of another
bridge element. The positively charged residues in the post site
involving the lasso (Arg769, Arg764, and Arg975) are positioned
adjacent to a highly negatively charged patch on the DID located
at its convex surface toward the end of the long axis (Glu227,
Glu229, Glu230, Glu268, Glu272, Glu276, and Glu279). The DD
also contacts a region adjacent to the post site between two actin-
binding sites. Thus, the structure suggests that this tetrameric form
of the complex would be inhibited for nucleation and processive
capping due to an inability to bind actin monomers and filaments.
This mechanism is analogous to that seen in many autoinhibited
systems, where a regulatory domain binds directly to the active site
of a functional domain, blocking its interactions with substrates/
ligands [39].
In the crystal, the tetramer makes contacts with other tetramers
through interactions between the (DID-DD)2 dimers. On the basis
of this interaction it is possible to generate two alternative
tetrameric configurations in addition to that shown in Figure 2A
(Fig. S4). In these configurations, the tetramer consists of a pair of
(DID-DD)2N(bridge-DAD)2 dimers held together by contacts
between the (DID-DD)2 elements. Inhibition in these systems
would occur through the mechanisms described below for
potential mDia1 dimers. In these alternative tetramers, dissocia-
tion of (DID-DD)2-(DID-DD)2 contacts could explain the dimer-
tetramer equilibrium observed in the analytical ultracentrifugation
and MALS data. Regardless of exactly which tetramer (or
combinations thereof) predominates in solution, the domain-
domain contacts within mDia1 are likely to be quite dynamic,
since the system can generate the intertwined tetramer in the
crystal as described above. Indeed the lasso-post interface was
swapped during crystallization of the yeast FH2-actin complex in a
previous study [21], suggesting that domain-domain contacts may
be generally dynamic in formins.
Possible Autoinhibitory Mechanisms of an mDia1 Dimer
Although the structure of the (DID-DD)4N(bridge-DAD)4
tetramer explains clearly why it is inactive, full length mDia1
contains only two copies of each element. Can the tetramer
structure suggest mechanisms of autoinhibition in the intact
protein? Although the dimeric pairing of bridge elements to
produce the functional FH2 domain cannot be definitively
determined in our structure, it is possible to extract (DID-
DD)2N(bridge-DAD)2 complexes from the tetramer. Below, we
describe four possible structures and their relevance to autoinhibi-
tion in the mDia1 dimer (Fig. 3). A common assumption in all of
the models is that the (DD)2 dimer, and therefore the DID-DID
pairing, observed in the crystal is representative of the N-terminal
dimer in the full-length protein. This assumption is based on the
high homotypic affinity in the dimeric N-terminus [32] and the
high structural similarity between the (DD)2 domain in the
tetramer here and the three previously reported structures of the
mDia1 N-terminus[34,35,40].
For the first model, the (DID-DD)2 pair is coupled to the two
bridge-DAD elements specified by the DIDNDAD interaction in
the tetramer (Model 1, Fig. 3B). In this model, the (DID-DD)2
dimer sits over the bridge elements in the pointed-end direction
(compare Figs. 3A and 3B). Here, the bridges have no contact with
Table 2. R.m.s.d. of backbone atoms of DID, DD, and DID-DD
between the molecule A of the DID-DDNFH2-DAD structure in








2BNX-molecule A 0.53 0.31 0.74
1Z2C 0.98 2.2 3.5
2BAP 1.5 1.9 4.8
2BNX-molocule B 0.61 0.28 10.5
The units are A ˚. 2BNX is the asymmetric dimeric structure of the free DID-DD-CC
[34]. 1Z2C is the symmetric dimeric structure of the G-DID-DDNRhoC complex
[35]. 2BAP is the symmetric dimeric structure of the DID-DDNDAD complex [40].
doi:10.1371/journal.pone.0012896.t002
binding to DID. The orientation of the figure is similar to the middle of (A). The dotted line indicates the hypothetical connecting linker (5 residues
1172-1176) whose electron density is missing. The Ile 1170 contacts the hydrophobic residues of DID and DAD so that the peak corresponding this
residue in the NMR experiment shows a shift from the free to the complex form (see also Fig. 4).
doi:10.1371/journal.pone.0012896.g002
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PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12896Figure 3. Structural models for mDia1 autoinhibition. (A) A structural model of the FH2 domain at a filament barbed-end is presented, in
which a cartoon actin filament is placed at the pointed-end side of the crystal structure of Bni1p FH2 domain bound to TMR-actin (PDB code: 1Y64).
(B-E) Structural models of the mDia1 (DID-DD)2N(FH2-DAD)2 dimer derived from the crystal. Dashed lines indicate linkers connecting the bridge
elements and DADs. For clarity, the invisible linkers connecting two bridge elements in each model are not indicated. The names and numbering for
each structural element in this figure are same as those in Figure 2 except (E) Model 4, in which two DIDs are labeled as DID-A and DID-B and the
bridge elements as BE-A and BE-B. (B) In Model 1, no swapping of aT is assumed. This leads to only one bridge element bound to each DID. The
dotted line is a 5 residue linker missing in the electron density map. In this configuration, the distance spanned between the two bridge elements by
the lasso (,30 residues not observed in the electron density) is 38 A ˚, as indicated in the figure. (C) For Model 2, two identical models are shown for
clearer presentation. The model on left possess the same (DID-DD)2 dimer as in (B) and (D). The right is composed of the other pair from the tetramer
and is to facilitate comparison with (A). The distance between the ends of dotted lines (Met1172 and Thr1179) is 73 A ˚, which is too long for the
missing linker (5 residues) to connect. This operation would require at least the C-terminal 3,5 turns of aT to melt. (D) Model 3 is a hybrid model
between Models 1 and 2, in which aT of BE4 is swapped. The distance spanned by the missing portion of the lasso is 58 A ˚, as indicated in the figure.
(E) In Model 4, the DIDNBE pairs in Model 1 were organized according to the asymmetric structure of free DID-DD (2BNX). Thus, the relative positions
within each DD-DIDNDAD-BE element are the same as in (B), i.e., the position of BE-A relative to DID-A, BE-B to DID-B (Model 4), BE1 to DID1, and BE2
to DID2 (Model 1) are all the same. However, the different organization of the two DIDs in Model 1 and the asymmetric (DID-DD)2 dimer results in a
different organization of the BEs in the two cases.
doi:10.1371/journal.pone.0012896.g003
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sites on each bridge are exposed to solvent. Nevertheless, if the
crystallographic orientation were rigidly adopted, the two bridge
elements would be positioned too closely to allow binding of actin
monomers (Fig. S5A). However, such rigidity is unlikely given the
known flexibility of the bridge-bridge and aT-DAD linkers, and
the likely fluctuations of aT in solution. In fact, we found that
introducing flexibility in aT by replacing a portion of the helix
with a Gly-Gly-Ser linker or by extension of the aT-DAD linker,
did not affect inhibition by G-DID-DD-CC (Fig. S6), indicating
that the rigidity of aT is not an important factor for autoinhibition.
This model thus suggests that one or two actin monomers might be
able to bind to bridge elements of the autoinhibited protein (see
also below). However, even with flexibility in the structure,
comparison of Figures 3A and 3B suggests that the (DID-DD)2
element would sterically clash with additional monomers that
attempted to extend a filament beyond this initial nucleus. This
suggests that autoinhibition may arise because of steric occlusion of
an actin filament by the (DID-DD)2 dimer. (Note that the activities
of the FH2 domain, i.e., de novo nucleation of filaments and
processive capping/elongation, both require filament binding.
Thus blocking filament binding in the autoinhibited state should
lead to inhibition.) This is consistent with previously reported
biochemical data showing that autoinhibited mDia1 does not bind
filaments in an actin sedimentation assay [44].
An alternative organization of the full-length dimer would
involve binding of the bridge pair in Model 1 to the other (DID-
DD)2 dimer (or equivalently binding of the (DID-DD)2 dimer in
Model 1 to the other bridge pair) (Fig. 3C, Model 2). This
interaction would invoke a DID-DAD domain swap during
crystallization, and would require melting of aT. The feasibility of
such operations is supported by our observation that increased
flexibility of aT does not affect inhibition by G-DID-DD-CC (Fig.
S6). In this model the two DIDs sit between the bridge elements,
and occlude both of the actin-binding sites as in the tetramer. In
this case, there are physical contacts between DID-DD and bridge
elements as described above for the tetramer (Fig. S3). However,
we failed to demonstrate interactions between DID-DD and
bridge element in solution NMR experiments. The
1H-
15N
TROSY-HSQC spectra of 250 mM
2H/
15N-labeled DID com-
plexed with unlabeled DAD in the absence and presence of
unlabeled DAD-less FH2 (250 mM) shows no peak shifts or
broadening (Fig. S7), indicating that there is no interaction
between DID and bridge at this concentration range (or the
population of the DID-bridge complex is too small to detect by this
method). Thus Model 2 is unlikely to be a highly populated
structure in the autoinhibited state of full-length mDia1.
Another possible model (Model 3, Fig. 3D) is comprised of the
(DID-DD)2 dimer in Model 1 and another pair of the bridge-DAD
(BE1 and BE4). This configuration also requires melting aTo f
BE4 to make the DID-DAD contacts as similarly discussed for
Model 2 above. Actin binding to BE4 is impaired by the described
physical contacts for the knob and post actin-binding sites. Actin
monomer should be accessible to the post site of BE1 but not to
the knob site due to steric clash of actin with BE4 (Fig. S5B). These
considerations suggest that Model 3 is also inhibited by the
incompatibility with actin monomer and filament binding.
One final possibility is that in the presence of the CC (or in the
full-length protein) the organization of the N- and C-termini is
different from any potential model created from the tetrameric
crystal structure. Specifically, since the CC element appears to
induce an asymmetric structure in the (DID-DD-CC)2 dimer [34],
it is possible that in the autoinhibited full-length protein the N-
terminus adopts this same asymmetric conformation as well. In
Figure 3E (Model 4) we have modeled the two bridge-DAD
elements from the tetramer structure onto the asymmetric (DID-
DD-CC)2 dimer (PDB: 2BNX) using the DIDNDAD interactions in
the tetramer. In Model 4, the relative position and orientation of
the two bridge elements are completely different from that in the
tetrameric crystal structure. However, a similar mechanism of
autoinhibition emerges here as for Model 1. If the structure were
rigid, steric clashes would occur between actin monomers on one
bridge and either the neighboring bridge or the DID-DD,
depending on the binding site engaged (Figs. S5C and S5D). If
the structure were flexible (as is more likely), the overall
configuration would permit binding of the initial actin monomers,
but is incompatible with addition of further monomers to produce
a filament.
The four models presented here would respond to Rho
GTPases differently. Previous studies of mDia1 have shown that
Rho binds to the G-DID element competitively with the DAD,
and thus would cause dissociation of these intramolecular contacts
in the full length protein. In Models 1 and 4 one molecule of Rho
would be sufficient for activation, because disruption of a single
DID-DAD contact would enable the DID-DD element to swing
away from its position over the FH2 ring, allowing processive
capping to occur. In the case of Model 2, however, two molecules
of Rho would be required to expose both of the actin binding sites
that are covered by the (DID-DD)2 dimer. Since Model 3 is a
hybrid of Models 1 and 2, depending on which DIDNDAD contact
Rho disrupts, the number of Rho molecules could be one (when
Rho binds to DID 2) or two (when Rho binds to DID 1).
Binding of Monomeric Actin to the Autoinhibited
Complex
The common and most likely mechanism derived from the
above considerations invokes inhibition of filament binding by the
dimeric DID-DD N-terminus when tethered to the two DAD
elements emanating from the FH2 dimer. Since DID does not
contact FH2 directly, dimerization of the N-terminus is necessary
for inhibition, as a DID monomer bound to DAD would not be
constrained into the inhibitory configuration over the FH2 ring.
However, Li and Higgs have shown that a DID monomer can
inhibit FH2-DAD [32]. In that study, the concentration for
half inhibition by the DID monomer was about 120 nM, which
is consistent with the reported DID-DAD affinity (KD=
100,250 nM) [32,36,40]. These data suggest that the DID-
DAD interaction alone governs the inhibition without any need for
DID dimerization. To resolve this apparent conflict between
structural and biochemical data, we examined whether the
inhibitory action of monomeric DID is limited to the FH2 dimer
(two bridges) or if it could also block the activities of an engineered
monomeric bridge element [21]. In a standard actin assembly
assay, the monomeric bridge element nucleates filaments that
grow slowly at their pointed-ends while the barbed-ends are
blocked [20,21]. As shown in Figure 4A, we found that
stoichiometric concentration of a DID monomer (2 mM) inhibits
this activity of bridge-DAD (2 mM). These data led us to consider a
possibility in which bridge and DID may be joined through an
actin monomer in a way that inhibits filament nucleation or
growth. This mechanism would be consistent also with the dimer
models presented above: actin monomer could be incorporated
into the dimer models because the actin-binding sites are not
occluded and the dimeric architectures are likely flexible in
solution.
To begin testing this hypothesis, we took advantage of methyl-
TROSY NMR experiments to examine binding of the mDia1
FH2 domain to monomeric actin [21]. The d1 methyl resonances
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located at the C-terminal end of aT (Fig. 2D) are very intense
compared to the other isoleucine resonances in the bridge-DAD
protein (Fig. 4B, resonances assigned by mutagenesis, see
Methods). These are the only two isoleucine sidechains in the
protein that are exposed to solvent. The Ile845 resonance is
significantly broadened upon addition of tetramethylrhodamine
(TMR)-actin compared to other signals in the spectrum (Fig. 4B),
likely due to a combination of chemical exchange and degradation
of the TROSY effect by protons on actin [21]. In contrast to
TMR-actin, addition of unlabeled DID to bridge-DAD did not
cause significant broadening of bridge resonances except Ile1170
(Figs. 4C and S8). The relative sharpness and unchanged peak
position (
1H and
13C chemical shifts) of the Ile845 resonance
suggests that Ile845 remains solvent-exposed in the DID complex
with bridge-DAD. The shift and the broadening in the Ile1170
resonance (again, assigned by mutagenesis of the complex) upon
binding to DID (Figs. 4B, 4C and S8) are consistent with contacts
of Ile1170 to the DID in the crystal structure of the tetramer
(Fig. 2D). When TMR-actin was added to the complex, the Ile845
Figure 4. BE-DAD is inhibited by DID but actin monomer is accessible to the knob site. (A) Pyrene actin assembly assays indicating that
DID inhibits BE-DAD-stimulated actin assembly. A cartoon representing the artificial BE-DAD construct is shown on the left. (B, C)
1H-
13C Ile d1 methyl-
TROSY HMQC spectra of 60 mM BE-DAD in the absence (B) or presence (C) of 72 mM DID are shown in black. The spectra in the presence of TMR actin
are shown in red. Asterisk indicates the isotope-labeled material (BE-DAD) and others are unlabeled. In both (B) and (C), addition of TMR actin causes
broadening and small shifts of the Ile845 resonance, indicating binding. Ile845 is located in the center of the knob actin binding site (Fig. 2C and refs.
[20,21]). The Ile1170 peak shifts upon addition of DID to BE-DAD (from (B) to (C)) because Ile1170 contacts the DID as shown in Fig. 2D. Ratios of the
intensities of red/black peaks are plotted for each peak on the right panels. The ratios for the Ile845 peaks are significantly smaller than the other
peaks in both (B) and (C), strongly suggesting that Ile845 interacts with actin.
doi:10.1371/journal.pone.0012896.g004
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indicating that actin monomer interacts with the knob site, even in
the presence of DID. Thus inhibition in the complex between
bridge-DAD and DID does not occur through occlusion of both
actin-binding sites, and could potentially involve a sandwich
structure between DID, actin and bridge-DAD. We have no
information on actin binding at the post site due to lack of an
appropriate NMR probe at this location of the molecule.
Analogous experiments to examine binding of actin to the knob
site of the (G-DID-DD-CC)2N(bridge-DAD)2 were inconclusive due
to the large size of the complex (221 kDa) and consequent poor
quality of the NMR data. Nevertheless, the accessibility of actin-
binding sites in the models of full-length mDia1 presented above
(Fig. 3), coupled with the ability of actin monomer to bind to the
inhibited DIDNbridge-DAD system (Fig. 4) suggests that auto-
inhibition may involve not only DIDNbridge-DAD complexes, but
also actin monomer as well.
Conclusion
We have discussed several possible mechanisms of autoinhibi-
tion of mDia1 based on our initial structure and proposed that
structural hindrance between actin filament and the bridge
elements, which occurs in the geometry of the autoinhibitory
state, is the likely one. Based on additional biochemical and NMR
data we also suggest the possibility that autoinhibition in full-
length mDia1 may involve actin monomer binding. Assessment of
the presented possible mechanisms will require structure determi-
nation of larger mDia1 constructs in future.
Materials and Methods
Protein preparation
The cDNA clone for mouse mDia1 (ID: 5042572, GI:
47124598) was purchased from Invitrogen and used as a PCR
template to subclone the various fragments used here. For the
oligomerization analyses of intact mDia1 protein, we used a
construct harboring residues 67–1209, which contains all of
functional domains in mDia1 (see Fig 1A; the yield of the complete
full-length mDia1 (1–1255) was very poor in E.coli and insect cells).
For simplicity, this slightly truncated construct is referred to as the
‘‘full-length’’ protein throughout the text. mDia1 full-length (67–
1209) was expressed in Sf9 (Spodoptera frugiperda) insect cells
(Invitrogen) by infecting with baculovirus carrying the mDia1
cDNA. The baculovirus was generated using Bac-to-Bac Baculo-
virus Expression System (Invitrogen) with a modified pFastBac
HTa plasmid (Invitrogen) carrying mDia1 (67–1209) at the NdeI-
XhoI sites (NdeI and a thrombin recognition sequence for His-tag
cleavage had been incorporated into the original pFastBac HTa by
linker ligation). The expressed Hig-tagged protein was purified
with Ni-Sepharose FF (GE healthcare) followed by MonoQ anion
exchange and Superdex 200 gel filtration columns. The His-tag
was cleaved off by thrombin (GE healthcare) before gel filtration.
The following pET vectors (Novagen) harboring mDia1
fragments at NdeI-XhoI sites were generated using standard
cloning procedures: pET32b for G-DID-DD-CC (residues 67–
570), pET11a for DID-DD (131–457), DID (131–370), FH2 (753–
1159) and FH2-DAD (753–1209). The genes for the following
artificial mDia1 fragments were generated by multiple PCR
reactions and cloned into the NdeI-XhoI sites of pET vectors:
pET41a for bridge-DAD (828-1209+15 repeats of (Gly-Gly-Ser) +
Ala-Met + 753-813), FH2-GGS20r-DAD (753–1151+6 repeats of
(Gly-Gly-Ser) + Gly-Gly + 1172–1209) and FH2-GGS30i-DAD
(753–1159+10 repeats of (Gly-Gly-Ser) + 1160–1209), or pET11a
for FH2-GGS12r-DAD (753–1159+4 repeats of (Gly-Gly-Ser) +
1172–1209). Proteins were expressed in E.coli BL21(DE3) at 20uC
overnight. None of these proteins contained any affinity tags; all
were purified using standard chromatographic columns: DEAE
sepharose, MonoQ, MonoS and Superdex 200 gel filtration
columns for the N-terminal fragments, and SP sepharose, MonoS
and Superdex 200 gel filtration columns for the C-terminal
fragments. The isoleucine d1-protonated, otherwise deuterated
proteins for methyl-TROSY NMR experiments were produced
using D2O M9 minimal media containing alpha-ketobutyric acid
(Isotec, USA) as a precursor for isoleucine as described [45]. Actin
was prepared from rabbit muscle and labeled with tetramethylr-
hodamine as described previously [46,47].
Pyrene actin assembly assays
Actin assembly assays using 5% pyrene actin were performed as
previously reported [48].
Determination of oligomerization states of mDia1
proteins
All samples used for determination of oligomerization were
passed through a gel filtration column to assure that there was no
aggregate, and to remove any excess of the N- or C-terminal
fragment from 1:1 stoichiometric complex. Sedimentation equi-
librium experiments were performed for the mDia1 autoinhibited
complexes (DID-DDNFH2-DAD and G-DID-DD-CCNFH2-DAD)
and the full-length protein (67–1209) using a Beckman XL-A
analytical ultracentrifuge with the four-position An60Ti rotor.
Protein complex solutions were loaded at initial concentrations of
7, 14, and 28 mM in 10 mM HEPES pH 7.0, 150 mM NaCl,
0.5 mM DTT. Data of absorbance at 280 nm were acquired at
three different speeds (6500, 9500, and 12000 rpm) at 20uC and
analyzed using a nonlinear least-square curve fitting program
Winnonln (Written by David Yphantis). Protein partial specific
volume and buffer viscosity were determined using Sednterp
(program written by David Hayes and Tom Laue). MALS
experiments of the wild-type FH2 domain of mDia1 autoinhibited
complexes were performed with on-line light scattering instrument
connected with a size exclusion column. 200 mlo f2 5mM mDia1
proteins were injected into Superdex 200 gel filtration column (GE
healthcare) equilibrated with 10 mM HEPES pH 7.0, 150 mM
NaCl 1 mM DTT. The light scattering was monitored with an 18-
angle light scattering detector (DAWN EOS) and refractive index
detector (Optilab DSP) (Wyatt Technology). Data were collected
every 0.5 s at a flow rate of 0.4 ml/min. Data analysis was carried
out using the program ASTRA version 4.90 (Wyatt Technology),
yielding the molar mass and mass distribution of the samples. No
band broadening correction was applied due to unavailability of
this function in this version of the ASTRA software. However, our
data generate reasonably flat molar masses, indicating that the
band broadening effect due to dilution between light scattering
and RI detectors was very small and not large enough to change
our interpretation of the oligomerization states of the mDia1
proteins.
Crystallization and X-ray diffraction data collection of the
DID-DDNFH2-DAD complex
Crystals of the mDia1 DID-DD (131–457)NFH2-DAD (753–
1209) complex in 10 mM HEPES pH 7.0, 150 mM NaCl, 1 mM
DTT were grown at 20uC using the hanging-drop vapor diffusion
method from drops containing 1 ml protein (30 mg/ml) and 1 mlo f
reservoir solution (100 mM MES pH 6.75, 12% (w/v) PEG1500).
Needle-shaped crystals appeared immediately upon setup and
grew to several hundred mm in one dimension but not in the other
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drops which had been pre-equilibrated versus 100 mM MES
pH 6.75, 10% (w/v) PEG1500, 25% sucrose for 24 hours before
seeding. Single crystals grew in this condition to 3006100660 mm
in one week, and were cryo-protected with 100 mM MES,
pH 6.75, 11.5% (w/v) PEG1500, 150 mM NaCl, 35% (v/v)
sucrose, and flash-cooled in liquid propane. All crystals (native and
selenomethionyl-substituted) were grown and cryoprotected in a
similar manner, and exhibit the symmetry of space group P21 with
cell dimensions of a=93.9 A ˚, b=208.5 A ˚, c=131.5 A ˚, b=102.7u
and contain four DID-DD and four FH2-DAD molecules in the
asymmetric unit. Native crystals diffracted to a dmin of 2.75 A ˚
when exposed to synchrotron radiation. Crystals of a complex of
selenomethionyl-substituted mDia1 DID-DD (131–457) and
native mDia1 FH2-DAD (753–1209) (SeMet #1) diffracted to a
dmin of 2.95 A ˚ when exposed to synchrotron radiation. Crystals of
a complex of native mDia1 DID-DD (131–457) and seleno-
methionyl-substituted mDia1 FH2-DAD (753–1209) (SeMet #2)
diffracted to a dmin of 3.45 A ˚ when exposed to synchrotron
radiation. All diffraction data were collected at beamline 19-ID
(SBC-CAT) at the Advanced Photon Source (Argonne National
Laboratory, Argonne, Illinois, USA). Data were indexed, inte-
grated and scaled using the HKL-2000 program package [49].
Data collection statistics are provided in Table 1.
Phase determination and structure refinement
Initial phases for the native mDia1 DID-DD (131-457)NFH2-
DAD (753-1209) complex were obtained via molecular replace-
ment in the program AMoRe [50] using a truncated version of
chain A of the previously determined structure of the mDia1 DID-
DD-CC (131–516) domain (PDB ID 2BNX) [34]. The molecular
replacement solution was verified and 60 selenium sites were
identified via an anomalous difference map using data collected at
the peak wavelength for selenium from the SeMet #1 crystals.
Phases for a two-wavelength selenium anomalous dispersion
experiment with SeMet #1 crystal data to a dmin of 2.95 A ˚ were
refined with the program MLPHARE [51], resulting in an overall
figure-of-merit of 0.20 for data between 35.0 and 2.95 A ˚. Phases
were further improved by four-fold averaging and density
modification with the program DM [52] resulting in a figure-of-
merit of 0.44. Clear density was seen in the map for the C-terminal
bridge element of mDia1. Manual placement and rebuilding of a
model for the mDia1 bridge element using the previously
determined structure of the core FH2 domain of mDia1 [41]
(PDB ID 1V9D) were performed in the program O [53].
Confirmation of the model building for the bridge element was
obtained via inspection of an anomalous difference map using data
collected at the peak wavelength for selenium from the SeMet #2
crystals. Refinement was performed with the native data to a
resolution of 2.75 A ˚ using the program PHENIX [54] with a
random 1.5% of all data set aside for an Rfree calculation. The
final model contains four mDia1 DID-DD (131–457)NFH2-DAD
(753–1209) complexes; included are residues 131–452, 754–805,
829–1195 of complex A; 132–192, 200–457, 754–805, 830–1196
of complex B; 131–452, 754–805, 830–1196 of complex C; and
131–457, 754–805, 830–1196 of complex D. The Rwork is 0.199,
and the Rfree is 0.261. A Ramachandran plot generated with
Molprobity [55] indicated that 94.1% of all protein residues are in
the most favored regions.
Methyl-TROSY NMR experiment
Isoleucine d1 methyl-protonation in the otherwise deuterated
background was employed for the bridge-DAD protein for methyl
TROSY HMQC experiments. 60 mM labeled bridge-DAD was
dissolved in the NMR sample buffer containing 10 mM Hepes,
pH7.0, 1 mM DTT, 100 mM KCl, 100 mM CaCl2, 100% D2O.
TMR-actin was stored at 400 mM protein concentration in 2 mM
Tris pH7.0, 100 mM CaCl2, 1 mM EGTA, 1 mM NaN3, 100%
D2O until use. When TMR-actin was added the NMR sample,
salts were also added to maintain the total concentration at
100 mM.
1H-
13C methyl-TROSY HMQC spectra were recorded
at 25uC using 800 MHz Varian INOVA NMR equipped with the
cryogenic triple resonance probe. Experimental time for each
spectrum was 4,8 hours. Data processing and analysis were
carried out using NMRPipe and NMRDraw [56] and the figure
was generated using NMRView [57].
Supporting Information
Figure S1 Deletion of the CC does not affect the oligomeriza-
tion state of the N-terminus. MALS data for (A) G-DID-DD-CC
and (B) DID-DD were obtained and analyzed as described in
Materials and Methods. The molar masses indicate that both
proteins are dimers in solution.
Found at: doi:10.1371/journal.pone.0012896.s001 (0.35 MB TIF)
Figure S2 DID-DD inhibits FH2-DAD as potently as G-DID-
DD-CC. 5 mM FH2-DAD was completely inhibited by 10 mMo f
(A) the G-DID-DD-CC dimer or (B) the DID-CC dimer in actin
assembly assays.
Found at: doi:10.1371/journal.pone.0012896.s002 (0.34 MB TIF)
Figure S3 Molecular contacts at the Knob and Post sites of
bridge elements. The view of this figure is roughly from the right
bottom of the right panel of Fig. 2A to DID1. The residues
mentioned in the text are shown as sticks.
Found at: doi:10.1371/journal.pone.0012896.s003 (2.68 MB TIF)
Figure S4 Alternative tetramers based on crystallographic
contacts. (A) Two crystallographic asymmetric units are shown.
The contacts between two (DID-DD)4N(FH2-DAD)4 tetramers are
indicated by purple circles. The top and bottom tetramers
correspond to the complex in Figure 2A. (B, C) Alternative
tetramers extracted from (A) are shown. In (B) two of the Model 1
dimer form a tetramer through indicated contacts. Similarly in (C)
two of the Model 2 dimer form a distinct tetramer. (D) An
expanded view of the crystallographic contacts. These contacts
involve residues immediately following the DD (in what would be
the DD-CC linker) and residues from the loops between a helices
in the armadillo structure of the DID. Nomenclature for the
indicated helices is from the previous work [34]. The two DD
extensions (residues 446-451) in the DID-DD dimer are in
extended conformation and aligned anti-parallel to each other.
(E) The structure of the free DID-DD-CC (PDB code: 2BNX)
shows a parallel configuration of the DD-CC linkers in the dimer,
presenting entirely different molecular surface at the site of the
crystallographic contacts discussed illustrated in panel D. This
difference in structure may explain why DID-DD-CC constructs
produce dimers while DID-DD constructs produce dimer-
tetramer mixtures.
Found at: doi:10.1371/journal.pone.0012896.s004 (3.88 MB TIF)
Figure S5 Demonstration of compatibility of actin binding to
Models 1 and 4. Actin was modeled onto (A) BE1 of Model 1, (B)
BE1 of Model 3, (C) BE-B of Model 4, and (D) BE-A of Model 4
(C) by superimposing the structure of the Bni1p bridge element
bound to two actin molecules (PDB code; 1Y64). Actin 1 in yellow
is bound to the post site of the Bni1p BE and Actin 2 in pink to the
knob site. Actin 1 and 2 are related by pseudo two fold symmetry
[21]). Observed steric clashes with actin are indicated by red
colored parts of mDia1. DAD is not colored in red only in this
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molecules and the other bridge (BE2) but not with DID-DD. In
(B), Actin 2 clashes with BE4. In (C), Actin 2 but not Actin 1
clashes with DD. In (D), Actin 2 clashes with BE-A but not with
DID-DD and CC potentially clashes with Actin 1.
Found at: doi:10.1371/journal.pone.0012896.s005 (2.84 MB TIF)
Figure S6 Introducing flexibility in aT does not affect inhibition
by the N-terminus. Inhibition of (A) FH2-DAD wild type or (B-D)
artificial constructs by the G-DID-DD-CC dimer was tested in
actin assembly assays. In (B), FH2-GGS12r-DAD, in which 12
residues in aT (1160–1171) were replaced with 4 repeats of Gly-
Gly-Ser sequence, shows actin assembly activity at a similar level
as wild type and can be inhibited. In (C), FH2-GGS20r-DAD
including replacement of 20 residues (1152–1171) shows slightly
less activity and can also be inhibited. In (D), FH2-GGS30i-DAD,
in which 10 repeats of Gly-Gly-Ser sequence was inserted between
1159-1160, shows similar activity and can also be inhibited.
Found at: doi:10.1371/journal.pone.0012896.s006 (0.66 MB TIF)
Figure S7 Isolated DIDNDAD complex does not interact with
the FH2 domain. An overlay of the 1H/15N HSQC spectra of the
complex of 15N-DID bound to unlabeled DAD shows no
significant changes in peak position or linewidth upon addition
of unlabeled FH2 domain (lacking DAD). Because of the high
molecular weight of the FH2 domain, even weak interactions
should have caused observable peak broadening. Thus it is very
likely that the FH2 domain does not interact with DID at a
measurable affinity when it is not tethered to the N-terminus
through the linked DAD.
Found at: doi:10.1371/journal.pone.0012896.s007 (0.72 MB TIF)
Figure S8 Peak intensities in the 1H-13C Ile d1 methyl-TROSY
HMQC spectra of BE-DAD in Figure 4. Raw peak intensities of
the spectra of BE-DAD in the (A) absence or (B) presence of
unlabeled DID (both in the absence of TMR-actin and shown in
black in Figs. 4B and 4C). In (C), the ratios of the intensities in (B)
divided by those in (A) for each peak are shown. The higher
intensity of the Ile1170 resonance in (A) indicates that the DAD
region is highly mobile in the free BE-DAD protein. In the
absence of actin, the Ile845 resonance is affected by DID to the
same extent as the unassigned peaks 1-8 (which represent residues
in the core of the BE), while the Ile1170 resonance is greatly
decreased on intensity (panel C). This is consistent with the DID
differentially decreasing the mobility of Ile1170 in the DAD
region. This behavior contrasts with that shown in Figures 4B and
C, where actin differentially broadens the Ile845 resonance.
Found at: doi:10.1371/journal.pone.0012896.s008 (0.28 MB TIF)
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